secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001437749-24-022162
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences closes $60M rights offering at $10/unit, oversubscribed 138%
------------------------------------------------------------------------------

- Raised $60M gross from 6M units; each unit = 1 share + 2 warrants to buy 0.5 share at $11.
- Subscriptions exceeded $83M from 800+ accounts, including Executive Chairman Robert Duggan.
- Post-offering shares outstanding: 61,228,332; warrants for up to ~6M additional shares issued.
- Proceeds to fund CellFX nsPFA products: Percutaneous Electrode, Cardiac Clamp, 360° Catheter.
- Warrants exercisable immediately for 5 years; redeemable if stock exceeds $16.50 or $22 for 20 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924022162/0001437749-24-022162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924022162/plse20240702_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer